Back to SYRE

Bellevue Group AG → SYRE

Bellevue Group AG SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$33.2M
Q3 2026
Peak value
$33.2M
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$260K
Q2 2026$20.2M
Q3 2026$606K
Q3 2026$33.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$33.2M373.1K——
Q3 2026$606K6.8K——
Q2 2026$20.2M227.0K——
Q2 2026$260K2.9K——

Other funds holding SYRE

Other Bellevue Group AG positions

RVMDW

REVOLUTION MEDICINES INC

$398.3M
ARGX

ARGENX SE

$386M
IONS

IONIS PHARMACEUTICALS INC

$377.7M
AMGN

AMGEN INC

$350.5M
GILD

GILEAD SCIENCES INC

$312M
VRTX

VERTEX PHARMACEUTICALS INC

$302.6M
AMGN

AMGEN INC

$301.1M
VRTX

VERTEX PHARMACEUTICALS INC

$298M